Chiu, Chia-Yu https://orcid.org/0000-0002-5241-3435
Amenta, Eva
Chavez, Violeta
Fukuta, Yuriko
Hasbun, Rodrigo
Article History
Received: 7 October 2022
Revised: 15 November 2022
Accepted: 5 January 2023
First Online: 1 February 2023
Declarations
:
: Dr. Rodrigo Hasbun has received research support and personal fees from Biofire and received personal fees from Melinta pharmaceuticals. All other authors declare that they have no conflict of interest.